Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-047412
Filing Date
2021-07-20
Accepted
2021-07-20 17:06:33
Documents
1
Period of Report
2021-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3868
  Complete submission text file 0001209191-21-047412.txt   5572
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KYTHERA BIOPHARMACEUTICALS, INC. 30930 RUSSELL RANCH ROAD, 3RD FLOOR WESTLAKE VILLAGE CA 91362
Business Address
Sandoval Elisabeth (Reporting) CIK: 0001632295 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 211101844